These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36122919)

  • 1. Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario.
    Gomes T; Kolla G; McCormack D; Sereda A; Kitchen S; Antoniou T
    CMAJ; 2022 Sep; 194(36):E1233-E1242. PubMed ID: 36122919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inequities in access to primary care among opioid recipients in Ontario, Canada: A population-based cohort study.
    Gomes T; Campbell TJ; Martins D; Paterson JM; Robertson L; Juurlink DN; Mamdani M; Glazier RH
    PLoS Med; 2021 Jun; 18(6):e1003631. PubMed ID: 34061846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic in Ontario, Canada: A population-based analysis.
    Ledlie S; Tadrous M; Bayoumi AM; McCormack D; Cheng C; Besharah J; Munro C; Gomes T
    Int J Drug Policy; 2024 May; 127():104392. PubMed ID: 38522177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'I don't chase drugs as much anymore, and I'm not dead': Client reported outcomes associated with safer opioid supply programs in Ontario, Canada.
    Schmidt RA; Kaminski N; Kryszajtys DT; Rudzinski K; Perri M; Guta A; Benoit AC; Bayoumi AM; Challacombe L; Hales J; Kenny K; Kolla G; O'Reilly E; Sereda A; Rai N; Strike C
    Drug Alcohol Rev; 2023 Nov; 42(7):1825-1837. PubMed ID: 37718646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada.
    Young S; Kolla G; McCormack D; Campbell T; Leece P; Strike C; Srivastava A; Antoniou T; Bayoumi AM; Gomes T
    Int J Drug Policy; 2022 Apr; 102():103601. PubMed ID: 35124413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Controlled Trial of Electronic Care Plan Alerts and Resource Utilization by High Frequency Emergency Department Users with Opioid Use Disorder.
    Rathlev N; Almomen R; Deutsch A; Smithline H; Li H; Visintainer P
    West J Emerg Med; 2016 Jan; 17(1):28-34. PubMed ID: 26823927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the fentanyl patch-for-patch program in Ontario, Canada.
    Tadrous M; Greaves S; Martins D; Nadeem K; Singh S; Mamdani MM; Juurlink DN; Gomes T
    Int J Drug Policy; 2019 Apr; 66():82-86. PubMed ID: 30743092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-care resource use among patients who use illicit opioids in England, 2010-20: A descriptive matched cohort study.
    van Hest N; Brothers TD; Williamson A; Lewer D
    Addiction; 2024 Apr; 119(4):730-740. PubMed ID: 38049387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cohort study examining emergency department visits and hospital admissions among people who use drugs in Ottawa, Canada.
    Kendall CE; Boucher LM; Mark AE; Martin A; Marshall Z; Boyd R; Oickle P; Diliso N; Pineau D; Renaud B; Rose T; LeBlanc S; Tyndall M; Lee OM; Bayoumi AM
    Harm Reduct J; 2017 May; 14(1):16. PubMed ID: 28494791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between opioid use disorder and palliative care: a cohort study using linked health administrative data in Ontario, Canada.
    Lau J; Scott MM; Everett K; Gomes T; Tanuseputro P; Jennings S; Bagnarol R; Zimmermann C; Isenberg SR
    CMAJ; 2024 Apr; 196(16):E547-E557. PubMed ID: 38684285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribed safer opioid supply: A scoping review of the evidence.
    Ledlie S; Garg R; Cheng C; Kolla G; Antoniou T; Bouck Z; Gomes T
    Int J Drug Policy; 2024 Mar; 125():104339. PubMed ID: 38335867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the impact of an opioid-specific education series on rates of medication-assisted treatment for opioid use disorder in veterans.
    Kirby T; Connell R; Linneman T
    Am J Health Syst Pharm; 2021 Feb; 78(4):301-309. PubMed ID: 33289022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Access Addiction Medicine Clinics for People With Problematic Opioid Use.
    Corace K; Thavorn K; Suschinsky K; Willows M; Leece P; Kahan M; Nijmeh L; Aubin N; Roach M; Garner G; Saskin R; Kim E; Rice D; Taha S; Garber G; Hutton B
    JAMA Netw Open; 2023 Nov; 6(11):e2344528. PubMed ID: 37991762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of emergency department opioid use on future health resource utilization among patients with migraine.
    Shao Q; Rascati KL; Lawson KA; Wilson JP; Shah S; Garrett JS
    Headache; 2021 Feb; 61(2):287-299. PubMed ID: 33599982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the population-level effects of oxycodone restrictions on prescription opioid utilization in Ontario.
    Rudoler D; Kurdyak P; Gomes T; Huang A; Jones W; Littleford S; Paracha N; Fischer B
    Pharmacoepidemiol Drug Saf; 2022 Jul; 31(7):769-778. PubMed ID: 35470515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care utilization in medically complex people living with HIV before and after admission to an HIV-specific community facility: a pre-post comparison study.
    Stewart A; Antoniou T; Graves E; Plumptre L; Carusone SC
    CMAJ Open; 2021; 9(2):E460-E465. PubMed ID: 33958381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographic variation in the provision of naloxone by pharmacies in Ontario, Canada: A population-based small area variation analysis.
    Antoniou T; McCormack D; Campbell T; Sutradhar R; Tadrous M; Lum-Wilson N; Leece P; Munro C; Gomes T
    Drug Alcohol Depend; 2020 Nov; 216():108238. PubMed ID: 32891910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased health care utilization and health care costs in the inpatient and emergency department setting following initiation of ketogenic diet in pediatric patients: The experience in Ontario, Canada.
    Whiting S; Donner E; RamachandranNair R; Grabowski J; Jetté N; Duque DR
    Epilepsy Res; 2017 Mar; 131():51-57. PubMed ID: 28259032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using synthetic controls to estimate the population-level effects of Ontario's recently implemented overdose prevention sites and consumption and treatment services.
    Panagiotoglou D; Lim J
    Int J Drug Policy; 2022 Dec; 110():103881. PubMed ID: 36274565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription opioid characteristics at initiation for non-cancer pain and risk of treated opioid use disorder: A population-based study.
    Papadomanolakis-Pakis N; Moore KM; Peng Y; Gomes T
    Drug Alcohol Depend; 2021 Apr; 221():108601. PubMed ID: 33618194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.